[XENE] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -25.20%
YoY- -130.37%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 16 264 15 16 376 413 413 -88.48%
PBT -8,065 -7,742 -7,380 -7,517 -6,004 -7,714 -6,016 21.51%
Tax 14 -902 -513 -470 542 383 -350 -
NP -8,065 -7,742 -7,380 -7,517 -6,004 -7,714 -6,016 21.51%
Tax Rate - - - - - - - -
Total Cost 8,081 8,006 7,395 7,533 6,380 8,127 6,429 16.42%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -50,406.25 -2,932.58 -49,200.00 -46,981.25 -1,596.81 -1,867.80 -1,456.66 955.06%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.45 -0.43 -0.41 -0.42 -0.33 -0.51 -0.42 4.69%
EPS Diluted -0.45 -0.43 -0.41 -0.42 -0.33 -0.51 -0.42 4.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.